EBITDA
The latest quarterly ebitda is $406.77 Million with a quarter-over-quarter change of -0.28%. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) measures a company's operating performance by removing non-cash charges and capital structure effects.
DOC EBITDA
Reported quarterly EBITDA; no daily interpolation.
DOC Quarterly EBITDA Growth (YoY)
EBITDA growth vs the same quarter one year earlier, last 20 quarters.
Current EBITDA
$406.77M
$406.77 Million
Quarter-over-Quarter Change
-0.28%
vs. $407.92M prior quarter
Historical Data
57
Quarters of data available
Quarterly EBITDA History
| Period | EBITDA | QoQ Change | % Change |
|---|---|---|---|
| Q1 2026 | $406.77M | $-1.15M | -0.28% |
| Q4 2025 | $407.92M | +$13.88M | +3.52% |
| Q3 2025 | $394.04M | $-3.36M | -0.85% |
| Q2 2025 | $397.40M | $-6.22M | -1.54% |
| Q1 2025 | $403.63M | +$6.59M | +1.66% |
| Q4 2024 | $397.03M | +$131,000 | +0.03% |
| Q3 2024 | $396.90M | +$1.94M | +0.49% |
| Q2 2024 | $394.96M | +$55.43M | +16.32% |
| Q1 2024 | $339.53M | +$31.84M | +10.35% |
| Q4 2023 | $307.69M | +$7.28M | +2.42% |
| Q3 2023 | $300.42M | +$2.76M | +0.93% |
| Q2 2023 | $297.66M | +$19.61M | +7.05% |
| Q1 2023 | $278.04M | +$31.94M | +12.98% |
| Q4 2022 | $246.10M | $-29.55M | -10.72% |
| Q3 2022 | $275.65M | $-2.46M | -0.88% |
| Q2 2022 | $278.11M | +$10.81M | +4.05% |
| Q1 2022 | $267.29M | +$9.38M | +3.64% |
| Q4 2021 | $257.92M | +$1.86M | +0.73% |
| Q3 2021 | $256.06M | $-5.96M | -2.28% |
| Q2 2021 | $262.02M | +$13.40M | +5.39% |
| Q1 2021 | $248.61M | +$33.77M | +15.72% |
| Q4 2020 | $214.84M | $-35.58M | -14.21% |
| Q3 2020 | $250.42M | +$4.59M | +1.87% |
| Q2 2020 | $245.83M | +$60.34M | +32.53% |
| Q1 2020 | $185.49M | $-76.30M | -29.14% |
| Q4 2019 | $261.79M | $-5.14M | -1.93% |
| Q3 2019 | $266.93M | +$16.48M | +6.58% |
| Q2 2019 | $250.45M | +$4.58M | +1.86% |
| Q1 2019 | $245.87M | +$2.88M | +1.18% |
| Q4 2018 | $243.00M | $-8.32M | -3.31% |
| Q3 2018 | $251.31M | $-21.86M | -8.00% |
| Q2 2018 | $273.17M | $-4.30M | -1.55% |
| Q1 2018 | $277.47M | +$54.37M | +24.37% |
| Q4 2017 | $223.10M | $-52.06M | -18.92% |
| Q3 2017 | $275.16M | $-9.32M | -3.28% |
| Q2 2017 | $284.48M | $-26.13M | -8.41% |
| Q1 2017 | $310.61M | +$351.28M | +863.73% |
| Q4 2016 | $-40.67M | $-348.73M | -113.20% |
| Q3 2016 | $308.06M | $-28.41M | -8.44% |
| Q2 2016 | $336.48M | +$17.43M | +5.46% |
| Q1 2016 | $319.05M | $-154.63M | -32.64% |
| Q4 2015 | $473.68M | +$10.23M | +2.21% |
| Q3 2015 | $463.45M | +$21.11M | +4.77% |
| Q2 2015 | $442.35M | $-11.64M | -2.56% |
| Q1 2015 | $453.99M | $-12.35M | -2.65% |
| Q4 2014 | $466.33M | $-11.23M | -2.35% |
| Q3 2014 | $477.56M | +$41.96M | +9.63% |
| Q2 2014 | $435.60M | +$2.21M | +0.51% |
| Q1 2014 | $433.39M | $-10.75M | -2.42% |
| Q4 2013 | $444.13M | +$18.72M | +4.40% |
| Q3 2013 | $425.41M | +$11.12M | +2.69% |
| Q2 2013 | $414.29M | $-3.55M | -0.85% |
| Q1 2013 | $417.84M | +$9.34M | +2.29% |
| Q4 2012 | $408.50M | +$32.51M | +8.64% |
| Q3 2012 | $376.00M | +$460,000 | +0.12% |
| Q2 2012 | $375.54M | +$7.13M | +1.94% |
| Q1 2012 | $368.40M | — | — |
About Healthpeak Properties, Inc.
Healthpeak Properties, Inc. is an S&P 500 constituent operating as a fully integrated real estate investment trust (REIT). The firm is dedicated to the acquisition, management, and development of premier properties essential for both medical research and the provision of healthcare services.
- Sector
- Real Estate
- Industry
- REIT - Healthcare Facilities
- CEO
- Scott Brinker